Mandaya Royal Hospital Puri continues to expand its capacity in blood cancer care by presenting five experienced blood specialists, also known as Medical Hematology Oncology Consultants (KHOM). The presence of this subspecialist medical team enables the Mandaya Blood Cancer Center to perform bone marrow transplantation or Hematopoietic Stem Cell Transplantation (HSCT), one of the key therapies in managing various blood disorders such as leukemia, lymphoma, and multiple myeloma.
The availability of bone marrow transplant services at Mandaya Royal Hospital Puri represents a major step forward in delivering high-standard blood cancer care in Indonesia. With adequate facilities and medical expertise, patients can now receive comprehensive treatment without the need to seek care abroad.
Contents
Understanding HSCT or Bone Marrow Transplantation
Hematopoietic Stem Cell Transplantation (HSCT), commonly known as bone marrow transplantation, is a medical procedure aimed at replacing damaged or non-functioning stem cells with healthy ones. Stem cells play a vital role as the foundation of blood cell formation and are essential for maintaining immune system function.
The HSCT procedure consists of five main stages: conditioning, stem cell collection, transplantation, engraftment, and recovery.
During the conditioning phase, patients undergo chemotherapy and/or radiation therapy to eliminate cancer cells while preparing the body to receive new stem cells. Once this stage is completed, donor stem cells are collected and infused into the patient’s bloodstream.
These stem cells then migrate to the bone marrow and begin forming new, healthy blood cells. The process in which new stem cells settle and start functioning in the bone marrow is known as engraftment. After engraftment is achieved, patients enter the recovery phase and receive various supportive therapies to optimize the healing process.
KHOM Medical Team at the Mandaya Blood Cancer Center
Medical Hematology Oncology Consultants (KHOM), commonly referred to as blood specialists, are physicians with specialized expertise in diagnosing and treating various blood disorders, including blood cancers.
To support integrated and comprehensive blood cancer services, Mandaya Royal Hospital Puri is supported by five KHOM consultants who manage a wide range of conditions, including Hodgkin and Non-Hodgkin lymphoma, leukemia, and multiple myeloma.
Below are the five KHOM consultants at the Mandaya Blood Cancer Center:
1. dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM
dr. Toman T.J. Lumban Toruan, Sp.PD-KHOM is an internal medicine specialist with subspecialty training in Medical Hematology-Oncology and extensive experience in treating various types of blood cancer. He completed his medical education at the Faculty of Medicine, University of Indonesia, followed by internal medicine specialist training at Cipto Mangunkusumo Hospital. In addition, he undertook an Honorary Fellowship (Clinical Observership) at the Department of Hematology, National University Hospital (NUH), Singapore.
In his clinical practice, dr. Toman is proficient in various modern therapeutic modalities, including chemotherapy, immunotherapy, targeted therapy, and apheresis procedures for specific hematologic conditions.
Practice Schedule at Mandaya Royal Hospital Puri:
- Tuesday: 12.00 – 15.00 WIB
- Thursday: 12.00 – 15.00 WIB
2. dr. Alvin Tagor Harahap, Sp.PD-KHOM
dr. Alvin Tagor Harahap, Sp.PD-KHOM is an internal medicine specialist with subspecialty training in Medical Hematology-Oncology who completed both his general medical and specialist education at the Faculty of Medicine, University of Indonesia. He has strong competence in managing various blood cancers and other hematologic disorders using a comprehensive medical approach.
His services include chemotherapy, immunotherapy, targeted therapy, and apheresis procedures, tailored to each patient’s clinical condition and individual needs.
Practice Schedule at Mandaya Royal Hospital Puri:
- Wednesday: 18.00 – 20.00 WIB
- Saturday: 10.00 – 12.00 WIB
3. Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP
Prof. DR. Aru W. Sudoyo, Sp.PD-KHOM, FINASIM, FACP is one of Indonesia’s leading figures in hematology and oncology. He completed his medical, internal medicine, and Medical Hematology-Oncology consultant training at the Faculty of Medicine, University of Indonesia, where he also earned his doctoral degree.
Prof. Aru is widely recognized for his contributions to the development of cancer services at the national level. His expertise includes advanced cancer therapies such as chemotherapy, immunotherapy, targeted therapy, bone marrow transplantation, and CAR-T cell therapy.
Practice Schedule at Mandaya Royal Hospital Puri:
- Wednesday: 08.00 – 12.00 WIB
4. Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM
Dr. dr. Andree Kurniawan, Sp.PD-KHOM, FINASIM is an internal medicine specialist and Medical Hematology-Oncology consultant with extensive experience in treating blood cancers and various hematologic disorders. He is proficient in multiple treatment approaches, including chemotherapy, immunotherapy, and targeted therapy.
In his practice, Dr. Andree applies a personalized approach focused on each patient’s clinical needs to achieve optimal treatment outcomes.
Practice Schedule at Mandaya Royal Hospital Puri:
- Monday: 17.00 – 19.00 WIB
- Thursday: 17.00 – 19.00 WIB
5. dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K)
dr. Nia Noviantri Siregar, Sp.PD, Subsp. H-Onk.M (K) is an internal medicine specialist and Medical Hematology-Oncology consultant focusing on blood cancer treatment and complex hematologic disorders. She is experienced in administering chemotherapy, immunotherapy, and targeted therapy using a comprehensive approach aligned with the latest medical advancements.
Practice Schedule at Mandaya Royal Hospital Puri:
- Tuesday: 17.00 – 20.00 WIB
- Friday: 17.00 – 20.00 WIB
Facilities at the Mandaya Blood Cancer Center
The Mandaya Blood Cancer Center at Mandaya Royal Hospital Puri is equipped with comprehensive medical services and facilities to support blood cancer patient care. All facilities are designed to ensure accurate diagnosis, optimal therapy, and holistic patient recovery.
Below are the leading services and facilities available:
1. Hematopoietic Stem Cell Transplant (HSCT)
HSCT is one of the flagship services at the Mandaya Blood Cancer Center. This procedure aims to replace bone marrow damaged by blood cancer with healthy blood-forming stem cells. Through this treatment, blood cell production can be gradually restored, helping improve the quality of life of blood cancer patients.
2. ICIR/PICIR Facilities (Immunocompromised Room)
To support the success of HSCT, Mandaya Royal Hospital Puri provides ICIR/PICIR facilities—specialized care rooms for blood cancer patients with compromised immunity. These facilities are an essential part of the HSCT care ecosystem, designed to minimize infection risk during treatment and recovery.
3. Irradiated Blood Transfusion
The Mandaya Blood Cancer Center also provides irradiated blood transfusion services. This process involves blood that has undergone irradiation to prevent serious complications such as Transfusion-Associated Graft-Versus-Host Disease (TA-GvHD). This service is particularly important for patients who have undergone stem cell transplantation or have severely weakened immune systems.
4. Comprehensive Systemic Therapy
Blood cancer treatment at Mandaya Royal Hospital Puri is supported by a wide range of comprehensive systemic therapies, including chemotherapy, immunotherapy, targeted therapy, and radiotherapy. Therapy selection is individualized based on the type of blood cancer, disease stage, and each patient’s clinical condition.
5. Digital PET/CT Scan
To support diagnosis, staging, and treatment response evaluation, Mandaya Royal Hospital Puri utilizes Digital PET/CT Scan technology. This advanced imaging enables physicians to assess cancer location, metabolic activity, and disease spread with greater accuracy and precision.
6. Flow Cytometry Examination
The Mandaya Blood Cancer Center also provides flow cytometry examinations as part of advanced hematology laboratory evaluation. This test is used to analyze blood cancer cell characteristics in depth and to monitor patient response to ongoing treatment.
7. Apheresis Services
As a complementary blood cancer service, Mandaya Royal Hospital Puri offers apheresis procedures. This medical intervention aims to reduce or separate abnormal blood components—such as excessive white blood cells in leukemia patients—and adjust blood components according to clinical needs, allowing symptoms to be controlled more effectively.
Mandaya–NUH Singapore Collaboration for More Precise Blood Cancer Treatment
The Mandaya Blood Cancer Center at Mandaya Royal Hospital Puri has established a strategic collaboration with the National Cancer Institute Singapore–National University Hospital (NCIS–NUH Singapore) to deliver more precise and personalized blood cancer care. This partnership is implemented through cross-border multidisciplinary case discussions, in which each patient is comprehensively evaluated by the Mandaya Royal Hospital Puri medical team together with experts from NCIS–NUH Singapore.
Through this collaboration, diagnostic confirmation, treatment strategy planning, and therapy selection can be carried out with a higher level of accuracy and tailored to each patient’s condition. Patients also have the opportunity to obtain a direct second opinion from internationally experienced blood cancer specialists.
Erwin Suyanto, Public Relation Manager of Mandaya Hospital Group, stated that the launch of the Mandaya Blood Cancer Center reflects Mandaya Royal Hospital Puri’s commitment to providing cancer services that are not only comprehensive but also integrated with world-class referral cancer centers. Cross-country expert discussions enable more targeted therapy recommendations, continuously improving the quality of blood cancer patient care.
Supported by comprehensive medical facilities and close collaboration with NCIS–NUH Singapore, Mandaya Royal Hospital Puri further strengthens its position as a leading cancer referral hospital in Indonesia, delivering international-standard blood cancer treatment services.
To make your visit to Mandaya Royal Hospital Puri easier, use the Chat via WhatsApp feature, Book Appointment, or the Care Dokter application available for download on Google Play and the App Store to schedule visits, view queue numbers, and access other complete information.
